Our editors also may be in touch with follow-up questions. Amino acid dietary supplements like L-tyrosine are often found in sports nutrition products, claiming to boost athletic performance and ...

(IN BRIEF) Novartis has announced promising 96-week results from the Phase III ASC4FIRST trial, showcasing Scemblix® (asciminib) as a superior treatment for newly diagnosed Philadelphia ...

Researchers at Children's Hospital of Philadelphia (CHOP) and the Children's Oncology Group (COG) found that larotrectinib, ...

Fintel reports that on December 10, 2024, BTIG initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a Buy ...

Scemblix resulted in better outcomes and fewer side effects compared to standard tyrosine kinase inhibitor therapies in ...

Sophia Humphreys, PharmD, MHA, BCBBS, a practicing pharmacist and health system director at Sutter Health, discussed the ...

L-tyrosine, categorized as a non-essential amino acid, is critical in creating neurotransmitters like dopamine, adrenaline, and noradrenaline. These are crucial to controlling mood, managing ...

Weiming Li, of Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has presented the latest clinical data of its novel drug candidate, olverembatinib (HQP1351) ...

NeuroQuiet is an innovative supplement designed to enhance overall cognitive function, improve auditory health, and elevate ...

Researchers identified 13 plasma proteins linked to brain aging, uncovering dynamic patterns and biomarkers for early ...

BTIG initiated coverage of Nurix Therapeutics (NRIX) with a Buy rating and $35 price target Nurix is a protein degrader company whose lead ...